Salta al contenuto principale
Passa alla visualizzazione normale.

ANDREA CORTEGIANI

High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future

Abstract

High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS). During the last 20 years, a growing body of evidence has shown the value of this intervention in the management of acute and chronic respiratory failure.